CeGaT Acquires Two Additional NovaSeq 6000 High-Throughput Sequencing Systems
April 11, 2022
Tübingen, Germany: CeGaT, a global provider of sequencing services for research, clinical studies, and human genetic diagnostics, is investing in new NovaSeq 6000 sequencing systems from Illumina. This acquisition is a strategically important move given CeGaT's rapid corporate growth. CeGaT has acquired a sixth and seventh NovaSeq 6000 to meet the increasing demand for sequencing [...]
April 11, 2022
Reiterates full year guidance and extends cash runway to H2 2024 BRANFORD, Conn. -- IsoPlexis Corporation (Nasdaq: ISO) (“IsoPlexis”), the Superhuman Cell Company, today announced its preliminary unaudited revenue for the first quarter of 2022 and the transition to an integrated commercial and operational structure, which is intended to ensure a sustainable growth path. Recent [...]
Standard BioTools Launches Hyperion+ Imaging System, the New Standard in High-Plex Spatial Imaging
April 11, 2022
Capacity to Process 100-Plus Samples per Week, with 1.6x Lower Limit of Detection SOUTH SAN FRANCISCO, Calif. -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – unleashing tools to accelerate breakthroughs in human health – today announced the launch of the Hyperion+™ Imaging System, the new standard in high-plex spatial imaging, providing lower limits of [...]
Bio-Rad Introduces Anti-Cemiplimab Antibodies
April 11, 2022
HERCULES, Calif. – Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today introduced a range of antibodies that are specific to cemiplimab (Libtayo) and inhibit the binding of the drug to its target, human programmed death receptor-1 (PD-1). These ready-made antibodies are suitable for developing [...]
Aviva Systems Biology Announces the Launch of High Throughput Antibody Characterization Services
April 11, 2022
SAN DIEGO -- Aviva Systems Biology, a market leader in antibodies, immunoassay kits, and recombinant proteins for life science research, today announced the launch of its new service offering for high throughput Antibody Characterization Services. Aviva Systems Biology's Antibody Characterization Services provides drug discovery researchers in small to mid-size biotechs with an affordable and easily accessible [...]
John Frank Joins Illumina as Chief Public Affairs Officer
April 11, 2022
SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced today the appointment of John Frank as the Company's Chief Public Affairs Officer (CPAO). Frank joins Illumina on April 18 from Microsoft Corporation; he will report to Chief Executive Officer Francis deSouza. As Illumina's Chief Public Affairs Officer, John [...]
April 11, 2022
EMERYVILLE, Calif. -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, and Vestaron Corporation, the leader in peptide-based crop protection, announced a strategic partnership to advance the development of pesticidal peptides as Active Ingredients (AIs) to improve the safety and efficacy of crop protection solutions for the global food supply. In this [...]
Atonarp Announces Key Additions to the Executive Leadership Team to Drive Next Phase of Growth
April 11, 2022
Tokyo – Atonarp, a leader advancing clinical diagnostics, life science research, semiconductor and industrial process control through digital molecular profiling, announces key additions to its executive team. Six seasoned executives have joined Atonarp to build the Company’s commercial team and launch the ASTON™ mass spectrometry platform, lead product development, plus leaders for marketing, business development, [...]
April 11, 2022
Bruker launches novel MALDI HiPLEX-IHC tissue imaging solution for timsTOF fleX using AmberGen’s HiPLEX-IHC peptide code antibody probes, combined with unbiased lipidomics, glycomics and metabolomics tissue imaging New Canopy CellScape™ single cell, highly quantitative spatial proteomic ChipCytometry™ platform features fully automated iterative staining using open-source antibodies for virtually unlimited immuno-oncology marker analysis on whole tissue [...]
April 11, 2022
Latest enterprise software release meets evolving industry needs in upstream biopharmaceutical characterization and facilitates implementation in downstream regulated environments Basel, Switzerland — Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced the release of Genedata Expressionist 16.0, the latest version of its platform for streamlining and automating mass spectrometry data workflows across [...]

